One of the greatest challenges clinical decision support programs have ismoving beyond a general alert to providing specific, timely, and useful information. Oncology seems like an ideal proving ground for this, given the complexity of cancer treatment and myriad factors that can help or hinder its treatment.
Two-thirds of cancer patients receive radiation as part of their initial treatment. But research suggests that half of these patients are at great risk of toxicity due to less than optimal radiation treatment planning.
That’s where Oncora Medical comes in. The predictive analytics startup focuses on radiation therapy and raised $1.2 million in seed financing from iSeed Ventures,BioAdvance, and medical physicist-entrepreneur, Dr. Thomas “Rock” Mackie. Oncora will use the funding to hire three to five engineers and roll out early product installations with a group of health systems. For the full article click here
from health IT caucus http://ift.tt/1UllOT7
via IFTTT
No comments:
Post a Comment